• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amazon Pharmacy Expands Access to Eli Lilly's Zepbound KwikPen for Weight Management

    3/9/26 7:32:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $AMZN alert in real time by email

    Amazon Pharmacy now offers customers transparent cash-pay pricing starting at $299 per month for the 2.5 mg KwikPen starter dose and convenient, fast home delivery.

    Amazon Pharmacy (NASDAQ:AMZN), a full-service digital pharmacy that delivers medications quickly and directly to customers' homes, today announced expanded access to the new Zepbound® KwikPen® through Amazon Pharmacy. Eli Lilly's multi-dose injectable treatment for weight management is designed to deliver a full month of medication in a single device, offering patients a more convenient alternative by reducing the number of single-dose devices required.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260309587894/en/

    Amazon Pharmacy sets itself apart in expanding access to the Zepbound KwikPen through Same-Day Delivery to more than half of U.S. households, a caregiver support feature for managing loved ones' prescriptions, 24/7 licensed pharmacist access and a full-service digital pharmacy offering a wide range of additional medications—all in one place.

    Amazon Pharmacy sets itself apart in expanding access to the Zepbound KwikPen through Same-Day Delivery to more than half of U.S. households, a caregiver support feature for managing loved ones' prescriptions, 24/7 licensed pharmacist access and a full-service digital pharmacy offering a wide range of additional medications—all in one place.

    With a valid prescription, customers can order Zepbound KwikPen through Amazon Pharmacy, see exactly how much the medication costs—starting at $299 per month for the 2.5 mg starter dose—through Amazon Pharmacy's transparent pricing before checkout, and have their medication delivered directly to their door.

    Eli Lilly's Zepbound is one of the most prescribed injectable weight management medications in the U.S. It has been shown to help adults lose weight and maintain weight loss when used alongside diet and exercise. It is also approved to help treat adults with obesity and moderate-to-severe obstructive sleep apnea.

    "Convenient access to medications and clear, transparent pricing are at the heart of what we do at Amazon Pharmacy," said Tanvi Patel, Vice President and General Manager of Amazon Pharmacy. "By expanding access to the Zepbound KwikPen with upfront self-pay pricing, we're making it easier for customers to get the treatments their doctors prescribe in a simpler way—delivered directly and reliably to their homes."

    Amazon Pharmacy has been delivering GLP-1 medications since 2021 and works with healthcare providers, industry collaborators, and digital health companies, including LillyDirect, WeightWatchers, UpScriptHealth and Noom, to expand access to weight management treatments. Amazon Pharmacy also offers 24/7 access to licensed and trained pharmacists and helps customers save on their medications by automatically applying manufacturer-sponsored coupons at checkout. To date, customers have saved more than $200 million through the automatic coupon program, with GLP-1 medications representing the largest category of savings.

    For customers seeking comprehensive care and additional support for weight management, Amazon One Medical offers personalized clinical evaluations, evidence-based treatment recommendations, and ongoing care management, including medication prescribing tailored to individual health needs and goals.

    Amazon Pharmacy customers nationwide receive free, fast delivery on their first order of each new medication — including Same-Day Delivery available to nearly 3,000 cities and towns today, expanding to nearly 4,500 by the end of 2026. Customers can visit pharmacy.amazon.com or choose Amazon Pharmacy in the Amazon app to get started or learn more.

    About Amazon Pharmacy

    Amazon Pharmacy is a full-service pharmacy that brings prescription medications directly to customers' doors with free two-day delivery for Prime members and same-day delivery in eligible locations. The service offers 24/7 access to pharmacists, transparent pricing, and multiple ways to save. Amazon Pharmacy accepts most insurance plans, automatically applies eligible manufacturer-sponsored coupons, and offers additional savings options for Prime members through RxPass and Prime Rx. For those managing multiple daily medications, PillPack from Amazon Pharmacy sorts medications by date and time into convenient packets, then delivers them to customers' doors at no extra cost.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260309587894/en/

    Amazon.com, Inc.

    Media Hotline

    [email protected]

    www.amazon.com/pr

    Get the next $AMZN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMZN

    DatePrice TargetRatingAnalyst
    2/23/2026$305.00 → $304.00Overweight
    Wells Fargo
    2/6/2026$300.00 → $280.00Buy
    Monness Crespi & Hardt
    2/6/2026$175.00Buy → Neutral
    DA Davidson
    2/2/2026$300.00 → $315.00Mkt Outperform
    Citizens JMP
    1/28/2026$305.00 → $315.00Outperform
    Oppenheimer
    1/28/2026$303.00 → $308.00Overweight
    KeyBanc Capital Markets
    1/27/2026$295.00 → $300.00Buy
    Stifel
    1/27/2026$303.00 → $286.00Buy
    BofA Securities
    More analyst ratings

    $AMZN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amazon Pharmacy Expands Access to Eli Lilly's Zepbound KwikPen for Weight Management

    Amazon Pharmacy now offers customers transparent cash-pay pricing starting at $299 per month for the 2.5 mg KwikPen starter dose and convenient, fast home delivery. Amazon Pharmacy (NASDAQ:AMZN), a full-service digital pharmacy that delivers medications quickly and directly to customers' homes, today announced expanded access to the new Zepbound® KwikPen® through Amazon Pharmacy. Eli Lilly's multi-dose injectable treatment for weight management is designed to deliver a full month of medication in a single device, offering patients a more convenient alternative by reducing the number of single-dose devices required. This press release features multimedia. View the full release here: https

    3/9/26 7:32:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    OpenAI and Amazon Announce Strategic Partnership

    Amazon Web Services (AWS) and OpenAI will co-create a Stateful Runtime Environment powered by OpenAI models, available on Amazon Bedrock for AWS customers to build generative AI applications and agents at production scale AWS will be the exclusive third-party cloud distribution provider for OpenAI Frontier, which enables organizations to build, deploy, and manage teams of AI agents OpenAI to consume 2 gigawatts of Trainium capacity through AWS infrastructure to support demand for Stateful Runtime Environment, Frontier, and other advanced workloads OpenAI and Amazon will develop customized models available to power Amazon's customer-facing applications Amazon will invest $50 billion

    2/27/26 8:30:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    National Safety Council Projects 12% Decrease in U.S. Traffic Fatalities in 2025

    Nine states and D.C. saw decreases of more than 15%WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Preliminary analysis from the National Safety Council estimates 37,810 motor vehicle crash deaths in the United States in 2025 – a 12% decrease from 2024, even as overall miles driven increased by 0.9%. Nine states and the District of Columbia experienced decreases of more than 15%: D.C. (-52%), California (-40%), Rhode Island (-29%), Iowa (-24%), Minnesota (-21%), Mississippi (-19%), New York (-18%), Connecticut (-16%), Maryland (-16%) and South Dakota (-16%). Eight states saw increases

    2/24/26 10:00:00 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO Worldwide Amazon Stores Herrington Douglas J sold $204,250 worth of shares (1,000 units at $204.25), decreasing direct ownership by 0.19% to 521,361 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    3/4/26 5:17:27 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    President and CEO Jassy Andrew R converted options into 49,680 shares and sold $4,077,378 worth of shares (19,872 units at $205.18), increasing direct ownership by 1% to 2,238,118 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    2/24/26 5:44:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    CEO Amazon Web Services Garman Matthew S converted options into 20,883 shares and sold $3,642,842 worth of shares (17,751 units at $205.22), increasing direct ownership by 50% to 9,405 units (SEC Form 4)

    4 - AMAZON COM INC (0001018724) (Issuer)

    2/24/26 5:37:55 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo reiterated coverage on Amazon with a new price target

    Wells Fargo reiterated coverage of Amazon with a rating of Overweight and set a new price target of $304.00 from $305.00 previously

    2/23/26 10:45:11 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Monness Crespi & Hardt reiterated coverage on Amazon with a new price target

    Monness Crespi & Hardt reiterated coverage of Amazon with a rating of Buy and set a new price target of $280.00 from $300.00 previously

    2/6/26 8:23:18 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon downgraded by DA Davidson with a new price target

    DA Davidson downgraded Amazon from Buy to Neutral and set a new price target of $175.00

    2/6/26 8:06:19 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 11, 2025 - FDA Roundup: March 11, 2025

    For Immediate Release: March 11, 2025 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:Today, the FDA published a General Correspondence Letter issued to Mid-Link Technology Testing Co., Ltd. The FDA is vigilant in ensuring data submitted to the FDA can be relied upon to assess the effectiveness, safety, or risk of a device. The FDA has noted an incr

    3/13/25 3:14:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    November 14, 2023 - FDA Roundup: November 14, 2023

    For Immediate Release: November 14, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA updated the advisory for the Investigation of Elevated Lead Levels in Cinnamon Applesauce Pouches to include an expanded recall from WanaBana LLC to include Weis and Schnucks-brand cinnamon applesauce pouches. As of November 13, 2023, there

    11/14/23 3:26:18 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    SEC Filings

    View All

    Amazon.com Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

    8-K - AMAZON COM INC (0001018724) (Filer)

    2/27/26 8:36:30 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form 13F-HR filed by Amazon.com Inc.

    13F-HR - AMAZON COM INC (0001018724) (Filer)

    2/10/26 4:13:45 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form S-3ASR filed by Amazon.com Inc.

    S-3ASR - AMAZON COM INC (0001018724) (Filer)

    2/6/26 7:38:34 AM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Leadership Updates

    Live Leadership Updates

    View All

    Circana Appoints Highly Regarded Business Leaders to Board of Directors

    Chicago, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Circana LLC, a leading global provider of data, insights, and advisory services, today announced the appointment of three new members to its Board of Directors: Brian Cornell, Executive Chair of Target Corp.; Lauren Cooks Levitan, Co-Founder and Co-CEO of ROOT and Lead Independent Director at e.l.f. Beauty, Inc.; and Rohit Prasad, former Senior Vice President and Head Scientist of Artificial General Intelligence at Amazon.com, Inc. "These appointments strengthen the Board's ability to guide Circana's strategy and accelerate the value we deliver to our global clients," said Stuart Aitken, President and CEO of Circana. "We are focused on advancing

    2/11/26 8:00:00 AM ET
    $AMZN
    $TGT
    Catalog/Specialty Distribution
    Consumer Discretionary
    Department/Specialty Retail Stores

    Hasbro Announces Additions to Board of Directors

    Doug Bowser and Carla Vernón to join as newest Board members Today, Hasbro, Inc. (NASDAQ:HAS), a leading games, IP and toy company, announced that Doug Bowser, retired President and Chief Operating Officer of Nintendo of America Inc., and Carla Vernón, Chief Executive Officer of The Honest Company, Inc. have been appointed to Hasbro's Board of Directors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120899535/en/ "We are delighted to have Doug and Carla join our seasoned and dynamic Board of Directors," said Rich Stoddart, Chair of Hasbro's Board of Directors. "Doug and Carla bring extensive leadership experience across co

    1/20/26 8:30:00 AM ET
    $AMZN
    $GIS
    $HAS
    Catalog/Specialty Distribution
    Consumer Discretionary
    Packaged Foods
    Consumer Staples

    Scientists Pointing to Hidden Power Source That Could Reshape Future of AI

    This article has been disseminated on behalf of MAX Power Mining Corp. and may include a paid advertisement. AUSTIN, Texas, Dec. 03, 2025 (GLOBE NEWSWIRE) -- MiningNewsWire: Global electricity demand is reaching a pivotal turning point. The International Energy Agency (IEA) now projects that global data-center electricity use will almost double by 2030, with AI-focused facilities increasing their consumption more than four times over the same span — a trajectory pushing power grids in the United States, China, Europe, Southeast Asia and other regions to their limits. The bottleneck is no longer data throughput or semiconductor performance; the critical constraint has become electricity it

    12/3/25 8:30:00 AM ET
    $AMZN
    $AVGO
    $META
    Catalog/Specialty Distribution
    Consumer Discretionary
    Semiconductors
    Technology

    $AMZN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    11/8/24 4:33:15 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Amazon.com Inc.

    SC 13G/A - AMAZON COM INC (0001018724) (Filed by)

    11/7/24 5:23:12 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    SEC Form SC 13G/A filed by Amazon.com Inc. (Amendment)

    SC 13G/A - AMAZON COM INC (0001018724) (Subject)

    2/13/24 4:55:57 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    $AMZN
    Financials

    Live finance-specific insights

    View All

    Amazon.com Announces Fourth Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its fourth quarter ended December 31, 2025. Fourth Quarter 2025 Net sales increased 14% to $213.4 billion in the fourth quarter, compared with $187.8 billion in fourth quarter 2024. Excluding the $2.8 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with fourth quarter 2024. North America segment sales increased 10% year-over-year to $127.1 billion. International segment sales increased 17% year-over-year to $50.7 billion, or increased 11% excluding changes in foreign exchange rates. AWS segment sales increased 24% year-over

    2/5/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon.com to Webcast Fourth Quarter 2025 Financial Results Conference Call

    Amazon.com, Inc. (NASDAQ:AMZN) announced today that it will hold a conference call to discuss its fourth quarter 2025 financial results on Thursday, February 5, 2026, at 2:00 p.m. PT/5:00 p.m. ET. The event will be webcast live, and the audio and associated slides will be available for at least three months thereafter at www.amazon.com/ir. View source version on businesswire.com: https://www.businesswire.com/news/home/20260122132654/en/ Amazon.com Public Relations [email protected] amazon.com/ir

    1/22/26 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary

    Amazon.com Announces Third Quarter Results

    Amazon.com, Inc. (NASDAQ:AMZN) today announced financial results for its third quarter ended September 30, 2025. Net sales increased 13% to $180.2 billion in the third quarter, compared with $158.9 billion in third quarter 2024. Excluding the $1.5 billion favorable impact from year-over-year changes in foreign exchange rates throughout the quarter, net sales increased 12% compared with third quarter 2024. North America segment sales increased 11% year-over-year to $106.3 billion. International segment sales increased 14% year-over-year to $40.9 billion, or increased 10% excluding changes in foreign exchange rates. AWS segment sales increased 20% year-over-year to $33.0 billion.

    10/30/25 4:01:00 PM ET
    $AMZN
    Catalog/Specialty Distribution
    Consumer Discretionary